As new agents reshape frontline and maintenance strategies in HER2-positive metastatic breast cancer, clinicians face growing challenges in applying evolving evidence and managing complex toxicities.Tune in to the second episode of this video podcast series to hear two oncology experts in HER2-positive breast cancer share practical insights on safety data and management of toxicities associated with emerging therapies in the frontline and maintenance setting.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 360 Park Avenue South
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Podcast / audio
- includes On-demand / recorded video
- Credit · Up to 0.25 credits
- MOC · Up to 0.25 points
- Commercial Support
-
ReleasedJun 25, 2026
-
Last day to claim creditJun 25, 2027 9 months left
-
PRIME Education, Inc. (PRIME®) Applying Frontline and Maintenance Evidence to Clinical Scenarios in Metastatic HER2+ Breast Cancer: A Case Panel Discussion
-
PRIME Education, Inc. (PRIME®) Reframing the Foundation: Frontline and Maintenance Therapy in HER2+ Metastatic Breast Cancer
-
PRIME Education, Inc. (PRIME®) Emerging Therapies in Frontline mTNBC: Safety Profiles and Adverse Event Management
-
Answers in CME Inc. (AiCME) Refining Care for HR+, HER2+ mBC in the Community: Contextualizing the Data for Emerging First-Line Maintenance Therapies
-
Clinical Care Options, LLC (dba Decera Clinical Education) Optimizing First-line Maintenance for HER2+ MBC: Equipping the Multidisciplinary Team With the Latest Evidence and Guidance on Novel Regimens
-
Efficient CME, CME Outfitters, LLC Reshaping the Paradigm: Expert Strategies and Ongoing Questions on the Implementation of Novel Frontline Strategies in HER2-Positive Metastatic Breast Cancer
